← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Genomas, Inc.
Hartford, CT
$6,186,955
Total funding
5
Grants
Funding over time
peak $1.6M · FY2005–13$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$6,186,955 · 5
By mechanism
R44$5,679,955 · 3
R43$507,000 · 2
Investigators at Genomas, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
DNA Diagnostic System for Statin Safety and Efficacy$670,537
R44 · FY2008 · GM
System for DNA-Guided Optimization and Personalization of Statin Therapy$641,098
R44 · FY2012 · GM
System for DNA-Guided Optimization and Personalization of Statin Therapy$605,509
R44 · FY2011 · GM
DNA Diagnostics for Minimizing Metabolic Side-Effects of Antipsychotics$497,546
R44 · FY2009 · MH
MRI DNA Biomarkers for Neuropsychiatric Disease$450,001
R44 · FY2009 · MH
MRI DNA Biomarkers for Neuropsychiatric Disease$449,992
R44 · FY2010 · MH
MRI DNA Biomarkers for Neuropsychiatric Disease$449,956
R44 · FY2011 · MH
DNA Diagnostics for Minimizing Metabolic Side-Effects of Antipsychotics$449,182
R44 · FY2007 · MH
DNA Diagnostics for Minimizing Metabolic Side-Effects of Antipsychotics$448,660
R44 · FY2008 · MH
DNA Diagnostic System for Statin Safety and Efficacy$338,062
R44 · FY2009 · GM
DNA Diagnostic System for Statin Safety and Efficacy$231,120
R44 · FY2009 · GM
Physiogenomic Arrays for Clinical Neuropsychiatry$200,000
R43 · FY2006 · MH
Physiogenomic Arrays for Clinical Neuropsychiatry$200,000
R43 · FY2005 · MH
System for DNA-Guided Optimization and Personalization of Statin Therapy$192,734
R44 · FY2013 · GM
DNA Diagnostic System for Statin Safety and Efficacy$143,338
R44 · FY2008 · GM
DNA Diagnostics for Minimizing Metabolic Side-Effects of Antipsychotics$112,220
R44 · FY2009 · MH
Gene Markers: Antipsychotic-Induced Metabolic Syndrome$107,000
R43 · FY2005 · MH